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Objectives: Unnecessary antibiotic prescribing contributes to antimicrobial resistance. A randomized controlled
trial in 2014–15 showed that a letter from England’s Chief Medical Officer (CMO) to high-prescribing GPs, giving
feedback about their prescribing relative to the norm, decreased antibiotic prescribing. The CMO sent further
feedback letters in succeeding years. We evaluated the effectiveness of the repeated feedback intervention.
Methods: Publicly available databases were used to identify GP practices whose antibiotic prescribing was in the
top 20% nationally (the intervention group). In April 2017, GPs in every practice in the intervention group
(n=1439) were sent a letter from the CMO. The letter stated that, ‘the great majority of practices in England pre-
scribe fewer antibiotics per head than yours’. Practices in the control group received no communication
(n=5986). We used a regression discontinuity design to evaluate the intervention because assignment to the
intervention condition was exogenous, depending on a ‘rating variable’. The outcome measure was the average
rate of antibiotic items dispensed from April 2017 to September 2017.
Results: The GP practices who received the letter changed their prescribing rates by #3.69% (95% CI=#2.29 to
#5.10; P<0.001), representing an estimated 124 952 fewer antibiotic items dispensed. The effect is robust to dif-
ferent specifications of the model.
Conclusions: Social norm feedback from a high-profile messenger continues to be effective when repeated. It
can substantially reduce antibiotic prescribing at low cost and on a national scale. Therefore, it is a worthwhile
addition to antimicrobial stewardship programmes.
Introduction
Antimicrobial resistance (AMR) is a growing public health threat.1 It
is estimated that 700000 people die of resistant infections every
year and that this number could rise to 10 million lives a year by
2050, with common procedures, such as surgery and chemother-
apy, becoming too dangerous to perform.2 One cause of the
problem is poor antimicrobial stewardship, with large quantities of
antibiotics being prescribed to patients who do not need them.2,3
In the UK, about 80% of antibiotics are prescribed in primary care.4
There is significant variation in prescribing between GP practices,
which cannot be explained by practice demographics, indicating that
many unnecessary antibiotics are being prescribed in primary care.5–7
As a part of its AMR stewardship strategy, the UK Government aims
to eventually give all health and care providers feedback in a for-
mat that is useable and relevant to support good practice.8
Giving GPs feedback on their practice’s performance compared
with other practices can decrease prescribing.9 In September
2014, we ran a randomized controlled trial (RCT) in which the Chief
Medical Officer (CMO) sent a feedback letter to 3227 GPs stating
that their practice was prescribing antibiotics at a higher rate than
80% of practices in its local area. As well as the social norm infor-
mation, the letter presented three specific, feasible actions that
the recipient could take to reduce unnecessary prescriptions of
antibiotics: giving patients advice on self-care, offering a delayed
prescription, and talking about the issue with other prescribers in
his or her practice. The letter was accompanied by a copy of the
‘Treating your infection’ leaflet [a part of the Treat Antibiotics
Responsibly, Guidance, Education, Tools (TARGET) Antibiotic
Toolkit],10 which aims to facilitate communication between
prescriber and patient, and increase the patient’s confidence to
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self-care. Between October 2014 and March 2015, the practices
in the intervention group dispensed 3.3% fewer antibiotic items
relative to the control group. The rate of dispensing antibiotics
differed significantly in every month in the study period, with no
evidence of a trend. Therefore, the feedback letter was sent to
the control group at the beginning of April 2015.
The rise in AMR is an issue of international concern,1,2 so the trial
had an international impact. The intervention has already been
adopted by CMOs in Australia,11 Northern Ireland12 and
Canada,13,14 and France is planning to follow suit.15
Following on from the success of the RCT, the CMO for England
has sent annual feedback letters to GPs whose practices are in the
top 20% of prescribers, each winter flu season. However, there is a
question of whether a repeated feedback intervention continues
to be effective.16 Because the CMO’s feedback was targeted at a
specific segment of practitioners, the top 20%, it is possible to use
a regression discontinuity design (RDD) to evaluate the subsequent
feedback intervention.
Methods
Intervention: letters to high antibiotic prescribers
The CMO sent her feedback letter on antibiotic prescribing rates to GPs in April
2017. The feedback letters were sent to 6318 individual GPs in 1439 different
GP practices with high antibiotic prescribing rates. Practices were allocated to
the intervention arm if they were in the top 20% of prescribers for the
12 months prior to the end of the intervention (between October 2015 and
September 2016), as judged using a prescribing indicator that divides antibac-
terial items by Specific Therapeutic group Age-sex Related Prescribing Units
(STAR-PU) weightings. This means that the prescribing rate is adjusted to take
into account some of the demographics of the GP practice.
The letters differed slightly from the 2014 trial;9 NHS Local Areas no
longer exist, so each practice’s prescribing was compared with that of
practices in England and additional guidance was presented in a box on the
right-hand side, instead of in the middle of the letter. There were six differ-
ent letters (Figures S1–S6, available as Supplementary data at JAC Online).
The letters were tailored according to GP practice prescribing rate, change
in prescribing over time and whether they were previously sent feedback.
Specifically, the top 11%–20% practices with increasing prescribing rates
were told ‘The great majority (80%) of practices in England prescribe fewer
antibiotics per head than yours. Most other practices have reduced their
prescribing rates since 2013/14 but yours has increased’ (Letter 1: Figures
S1 and S2); the rest of the top 20% were simply told ‘The great majority
(80%) of practices in England prescribe fewer antibiotics per head than
yours’ (Letter 2: Figures S3 and S4). Finally, the top 10% of practices
were told ‘The great majority (90%) of practices in England prescribe fewer
antibiotics per head than yours’ (Letter 3: Figures S5 and S6). When a prac-
tice had received a previous letter, the CMO noted, ‘I have written to your
practice previously’, so there were two variations of each letter, A and B.
Table 1 shows the key differences between the letter variants. As in the
2014 trial, the letter was accompanied by a copy of the TARGET ‘Treating
your infection’ leaflet (Figure S7).
RDD
We decided to use an RDD to analyse the effects of our intervention instead
of more conventional analytical approaches, such as an interrupted time
series (ITS) and difference-in-difference design. RDD is a standard approach
for evaluating interventions.17 In an RDD, the assignment of participants to
the intervention versus the control condition is exogenous, depending on
whether a numerical ‘rating variable’ falls above or below a certain thresh-
old. Participants scoring above the threshold are assigned to one group,
such as the treatment, whereas those scoring below the threshold are
assigned to another group, for example the control. The assumption behind
RDD is that, in a window around the threshold (the ‘bandwidth’), observa-
tions on each side are on average identical in terms of all pre-treatment
variables. There is a ‘local randomization’ in this window. There is also a
discontinuity in the probability of treatment at the threshold between the
treatment group and the control. Therefore, if there is a corresponding
discontinuity in the intercept of the regression of the outcome variable on
Table 1. Key differences between the six letter variations
Previous letter
(Paragraph 2 starts:
I have written to your
practice previously and. . .)
No previous
letter
Top 20%, prescribing increasing
Header:
Your practice is amongst the 20% highest prescribers of antibiotics nationally
Between Paragraph 1 and Paragraph 2:
The great majority (80%) of practices in England prescribe fewer antibiotics per head than yours. Most
other practices have reduced their prescribing rates since 2013/14 but yours has increased.
1A (Figure S1) 1B (Figure S2)
Top 20%, prescribing not increasing
Header:
Your practice is amongst the 20% highest prescribers of antibiotics nationally
Between Paragraph 1 and Paragraph 2:
The great majority (80%) of practices in England prescribe fewer antibiotics per head than yours.
2A (Figure S3) 2B (Figure S4)
Top 10%
Header:
Your practice is amongst the 10% highest prescribers of antibiotics nationally
Between Paragraph 1 and Paragraph 2:
The great majority (90%) of practices in England prescribe fewer antibiotics per head than yours.
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the predictor at the threshold level, the change in outcome is attributed
to the effect of the intervention.18 Critically, RDD can provide evidence for
the causal effect of an intervention because, controlling for the value of the
rating variable, it is possible to account for unobserved differences between
the treatment and the control groups.19–21
RDD is a quasi-experimental evaluation method that can be used in
cases where it would be impractical or unethical to assign participants to
different groups,17 for example, the impact of prisons on recidivism and the
impact of health insurance on improving service utilization.22,23 In the pre-
sent study, it is unethical to experimentally assign GP practices to different
experimental groups since we have reason to believe that the treatment is
effective, given the evidence from our previous trial.9 Therefore, we eval-
uated the intervention using a sharp RDD, a variation of the RDD where
the rating variable perfectly predicts treatment allocation.24 This means
that the probability of treatment changes from 0 to 1 at the threshold.
The rating variable was the prescribing indicator (average antibiotic
prescribing rate adjusted for STAR-PU) and the threshold was 1.14825
antibiotic items dispensed per STAR-PU, the cut-off point separating the
20% of highest prescribers from the remaining GP practices. We used
R,25 specifically a function called RDestimate of package rdd,26 to build
our RDD models.
Bandwidth size
One of the critical steps in RDD is selecting the bandwidth size around the
threshold to create the localized sample.27 This is because narrower band-
widths increase comparability between cases on each side of the threshold
while decreasing the statistical power, whereas wider bandwidths increase
power at the cost of decreasing internal validity by including cases further
away from the threshold. Hence, it is necessary to select the appropriate
bandwidth, which finds the balance between precision and power. The
Imbens–Kalyanaraman algorithm provides a data-driven, asymptotically
optimal bandwidth for RDD.27 The calculated bandwidth is tailored to spe-
cific features of the RDD setting. Using package rdd26 in R,25 we calculated
the optimal bandwidth size to create the localized sample around the
threshold that minimized bias and optimized precision. The optimal
bandwidth differed for the different models considered. For the most
parsimonious model (Table 2) the optimal bandwidth was 0.5234 anti-
biotic items dispensed per STAR-PU. Thus, practices within 0.5234 points
of the threshold in either direction were included in the local linear
regression analyses. The number of practices within this bandwidth
(n=6524), used to calculate the most plausible estimate of the local
average treatment effect (LATE), provided sufficient power to detect a
statistically significant effect at P<0.001.
Data
The data for this study came from the Public Health England data ware-
house (originally collected by the NHS Business Services Authority and NHS
Digital).28,29 These data consist of all GP practices in England who were sent
the April 2017 CMO feedback letter (n=1439), as well as the remaining
practices that served as the control group (n=5986). To account for differ-
ences in prescribing due to seasonality, we defined our baseline measure,
which we used to determine the percentile of prescribers that each practice
was in, as the mean STAR-PU-adjusted prescribing rate from October
2015 to September 2016. The outcome measure was the mean STAR-PU-
adjusted rate of antibiotic items dispensed during the intervention period
(April 2017 to September 2017).
Data preparation
We calculated our baseline and outcome measures using the same
quarterly antibacterial items/STAR-PU weightings that we used to select
the practices for letter allocations. For the analysis, we coded all the
practices that received the letter (20% of highest prescribers) as
the intervention group. The remaining practices, which did not receive
the letter because they were in the lower 21%–100% of prescribers,
were the control group.
We kept the GP practices in the central 99% of the records of both
baseline and outcome measures. This means that we removed practices
that were classified as outliers due to their extremely high or low rates of
prescribing (n=133), or due to extremely large/small patient populations
(n=57). We also removed practices due to instances of missing prescribing
data between October 2015 and September 2017 (n=231).
Since the CMO letters were sent only to the highest 20% of prescribers,
we aimed to set the RDD cut-off threshold at the fifth quintile. However, the
threshold was adjusted to 1.1812 from 1.1813 to account for the removal
of some practices (n=9) during data preparation, because of practice
changes over the intervention period or because of lack of STAR-PU data
for the duration of the intervention period. Overall, we removed 430 GP
practices. This resulted in the total sample of 6995 GP practices, 1378 of
Table 2. Differences in prescribing rates between treatment and control groups
Bandwidth Observations (n) Estimate (95% CI)
Standard




dispensed items (95% CI)
LATEa 0.523 6524 #0.016
(#0.010 to #0.023)
0.003 #5.141 <0.001 #3.69
(#2.29 to #5.10)
#124 952
(#77 544 to #172 698)
Half-bandwidth 0.262 4294 #0.015
(#0.007 to #0.023)
0.004 #3.832 <0.001 #3.42
(#1.67 to #5.17)
#115 810





0.003 #4.725 <0.001 #3.19
(#1.86 to #4.51)
#108 021






degrees of freedom P value
LATEa 2185 3 6520 <0.001
Half-bandwidth 461 3 4290 <0.001
Double-bandwidth 4205 3 6987 <0.001
aRepresents the optimal bandwidth.
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which received the letter in April 2017 (treatment group) and 5617 of which
did not (control group).
Data availability
The raw data are publicly and freely available from Fingertips, https://finger
tips.phe.org.uk/. The cleaned data set is available from the corresponding
author upon reasonable request.
Ethics
This study used publicly available data to evaluate an intervention, which
was not an RCT, so research ethics approval was not required.
Results
Table 2 and Figure 1 demonstrate the results of the simplest
model, where the baseline measure (average prescribing rate
adjusted for STAR-PU during the period October 2015 to
September 2016) is regressed on the outcome measure (average
prescribing rate adjusted for STAR-PU during the 6 months of the
intervention period). The RDD estimates can be interpreted as
weighted average effects of treatment across all GP practices. The
LATE estimate, which is calculated using the optimal bandwidth,
shows that the letter intervention resulted in a significant discon-
tinuity (b=#0.016, SE=0.003, z=#5.141, P<0.001); the GP practices
who received the letter changed their prescribing rates by approxi-
mately#3.69% (95% CI=#2.29 to#5.10). However, it is important
to acknowledge that deprivation levels could vary between the
local areas covered by GP practices in the treatment and the
control groups. This variation could affect prescribing rates of
GP practices. Thus, we adjusted the estimates for this potential
variation in deprivation using deprivation indices.30 We found that
the intervention effect was not sensitive to the inclusion of a de-
privation measure (Table 3). Moreover, although the effect size var-
ied depending on the bandwidth used, overall the effect remained
robust to halving or doubling the bandwidth, and therefore includ-
ing a different number of observations for both the unadjusted
and adjusted estimates. This indicates that our findings are likely
to be relatively reliable and valid.
We also built an RDD with a categorical variable specifying GP
practices’ allocation to one of six letters or the control group, to
examine whether the intervention was effective across all letter
types. We present the estimates for each letter type, both un-
adjusted and adjusted for deprivation, in Table 4. The four letters
sent to the top 11%–20% (Letters 1A, 1B, 2A and 2B) were esti-
mated to be relatively effective at reducing antibiotic prescribing
[1A: #5.21% (95% CI=#1.98 to #8.45); 1B: #4.75% (95%
CI=#2.96 to #6.54); 2A: #2.32% (95% CI=#0.45 to #4.18) and
2B: #3.81% (95% CI=#1.86 to #5.76)], with the letters sent to
those practices whose prescribing was increasing being most ef-
fective. However, for the practices in the top 10% (Letters 3A and
3B) our estimates of the intervention in the general population
were not clear. This is because the effects of the intervention for
the two letter types were not statistically significant [3A: #2.13%
(95% CI=0.76 to#5.02) and 3B: 1.47% (95% CI=7.24 to#4.30)].
Based on a predicted 3.69% reduction in antibiotic prescribing
for the intervention group over a 6 month period (Table 2), an esti-
mated 124952 fewer antibiotic items were dispensed during the
study as a result of the letter intervention. Specifically, we esti-
mated that 3386243 antibiotic items would have been dispensed


































Figure 1. Discontinuity based on the most parsimonious model. The solid vertical black line represents the discontinuity threshold between the
practices that received the letter (right side of the line) versus the practices that did not (left side of the line). The two dotted lines represent the
LATE bandwidth thresholds. The solid black regression line represents the point-based estimates of the RDD, whereas the two broken lines on either
side of it represent 95% CIs. Only 22 GP practices in the 10% of highest prescribers were outside of the optimal bandwidth thresholds, indicating
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arm, whereas 3261291 antibiotic items were found to have been
dispensed with the intervention.
To estimate the effect on direct prescribing costs for the public
sector, we considered the basic cost of a drug as used in primary
care during the intervention period, specifically the average net
ingredient cost (NIC) of £8.29 per antibiotic item.31 The NIC does
not take into account dispensing costs, fees or prescription charge
income. Thus, we assumed that 10.2% of antibiotics (12745)
incurred a £8.60 prescription charge (in line with the overall ex-
emption rate for April to September 2017), which we deducted
from the cost estimate.31–33 We also added the £1.25 per item
professional fee payable to pharmacy contractors by NHS England









dispensed items (95% CI)
LATEa 0.302 4814 #0.015
(#0.008 to #0.022)




Half-bandwidth 0.151 2546 #0.016
(#0.006 to #0.026)




Double-bandwidth 0.604 6744 #0.015
(#0.009 to #0.021)








of freedom P value
LATEa 530.6 4 4809 <0.001
Half-bandwidth 69.76 4 2541 <0.001
Double-bandwidth 2107.79 4 6739 <0.001
aRepresents the optimal bandwidth. Adjusted estimates are altered by the inclusion of a deprivation covariate (index of multiple deprivation
2015-based measure of population-weighted average of the lower layer super output areas covered by each practice).30
Table 4. Deprivation-adjusted difference in prescribing rates between treatment and control groups by letter
Letter type (n)a LATEb Bandwidth Observations (n) Estimate (95% CI)
Standard




dispensed items (95% CI)
1A (n =127) unadjusted 0.523 6524 #0.023
(#0.009 to #0.037)




adjusted 0.302 4814 #0.026
(#0.011 to #0.041)




1B (n =352) unadjusted 0.523 6524 #0.021
(#0.013 to #0.029)




adjusted 0.302 4814 #0.019
(#0.011 to #0.028)




2A (n =290) unadjusted 0.523 6524 #0.010
(#0.002 to #0.018)




adjusted 0.302 4814 #0.009
(#0.0003 to #0.018)




2B (n =289) unadjusted 0.523 6524 #0.017
(#0.008 to #0.025)




adjusted 0.302 4814 #0.014
(#0.004 to #0.023)




3A (n =250) unadjusted 0.523 6524 #0.009
(0.003 to #0.022)




adjusted 0.302 4814 #0.007
(0.007 to #0.021)




3B (n =70) unadjusted 0.523 6524 0.007
(0.032 to #0.019)




adjusted 0.302 4814 0.006
(0.031 to #0.020)




an indicates the number of practices that received each letter.
bCalculated using the optimal bandwidth for a given RDD. Adjusted estimates are altered by the inclusion of a deprivation covariate (index of multiple
deprivation 2015-based measure of population weighted average of the lower layer super output areas covered by each practice).30
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in 2017.32,33 The cost of printing and mailing to 6318 GPs in 1439
practices, which was deducted from the savings estimate to
produce a net savings estimate, was £5527. This equates to £0.04
per prescription prevented during the study period. Overall, the
predicted reduction in the number of prescribed antibiotics during
the intervention is estimated to have generated net savings of
£1076908 (£991842 if adjusted for practice deprivation) in NIC
and dispensing costs for the public sector.
Discussion
RDD analysis shows that the 2017 CMO feedback letter reduced
antibiotic prescribing by 3.69%, which is similar to the 3.3% reduc-
tion in prescribing that was found in the 2014 RCT.9 The finding
that repeated feedback continues to have an effect on antibiotic
prescribing is consistent with other trials that have used repeated
feedback in medicine and in other policy areas.34,35 A systematic
review has found that repeated feedback is more effective than
single instances in healthcare settings.36 However, these studies
tend to analyse the repeated feedback as a single intervention. To
our knowledge, this is the first study that investigates whether a
successful antibiotic feedback intervention can be as effective
when repeated. Our results suggest that the social norm feedback
intervention can be successfully implemented multiple times.
There were many antimicrobial stewardship interventions hap-
pening in the UK in 2017–18. For instance, the Quality Premium
gave financial incentives for reducing inappropriate prescribing,
the TARGET toolkit was developed (a suite of resources that health-
care workers can use to support patients to self-care), the
Antibiotic Guardian campaign encouraged professionals to pledge
to prescribe appropriately and the Keep Antibiotics Working cam-
paign was a patient-facing advertising campaign.37 Therefore, it
may not be a surprise that antibiotic prescribing in primary care is
decreasing.37 However, the RDD is a quasi-experimental method
of evaluation, and the difference between the groups within the
bandwidth is whether or not they received a letter, so we can attri-
bute the 3.69% difference in prescribing between groups to the
letter.
The intervention decreased prescribing amongst practices in
the top 11%–20%, especially those whose prescribing had been
increasing in the year beforehand; this decrease was observed
both in practices that had received a letter in the previous year and
in practices that had not received a letter. However, it did not have
a significant effect on practices in the top 10%. There are two types
of possible explanations for this difference. First, there may have
been something specific to the practices in the top 10%. Our
adjustments accounted for the age and sex of the practices’ pa-
tient populations (STAR-PU) and their deprivation. However, there
may have been other relevant factors that affect antibiotic pre-
scribing, for instance the prevalence of COPD or smoking, which
were not captured in our models. Second, there may have been
something about the message, which was more extreme for the
top 10%. Telling GPs that their practice was in the top 10% of pre-
scribers may have made their prescribing seem so disproportion-
ate that they felt they could not do anything about it. The forceful
message may have provoked psychological reactance, leading to
negative attitudes towards the message and the generation of
counterarguments, resulting in a lower behavioural intention to
comply with the message.38–40 Alternatively, while highly credible
sources are more persuasive the more discrepant the receiver finds
the message, moderately credible sources may be less persuasive
when they send a highly discrepant message. If the CMO is
only perceived as a moderately credible source, then the highly
discrepant message received by the top 10% of prescribers may
have been less persuasive than the less discrepant message
received by the top 20%.41,42
The intervention has already been used successfully in
Australia, Ireland and Canada, and France is planning to follow
suit.11–15 The countries that are implementing the intervention
are fairly similar culturally; they are all ‘western educated industri-
alized rich democracies’.43 It is possible that the effect of descrip-
tive norms and therefore the international applicability of the
intervention might vary between cultures. The strength of social
norms in countries is thought to vary along a spectrum that ranges
from ‘tight’ (have many strong norms and a low tolerance of devi-
ant behaviour) to ‘loose’ (have weak social norms and a high toler-
ance of deviant behaviour), and the UK, Australia and France are in
the middle of the spectrum.44,45 We might anticipate that the
feedback letter intervention would be least effective in the coun-
tries with the loosest cultures (Estonia, Hungary and Ukraine) and
most effective in countries with the tightest cultures (India,
Malaysia, Pakistan, Singapore and South Korea). However, this is
very speculative because the way that primary care is delivered
and that antibiotic prescribing occurs may differ in these countries,
and because the UK has lower antibiotic prescribing than many
countries.46
Our study has several limitations. First, the STAR-PU data were
calculated on a quarterly rather than a monthly basis. Therefore, it
is not currently possible to detect the exact extent of the discon-
tinuity in a specific month of an intervention. The strength of the
intervention may differ over the course of the outcome, but this
may be masked by the 3 month average of the outcome variable.
Thus, we can conclude that there was a difference in prescribing
over the entire evaluation period, but we are not able to detect
time trends, if they exist. Future studies, conditional on fine-
grained longitudinal data, could utilize an ITS to address that.
Second, the RDD tends to be less precise than a comparable
RCT. An RDD sample has to be at least 2.4 times greater than that
of an equivalent randomized trial in order to achieve the same
level of precision.24 Moreover, the precision of an RDD is sensitive to
the distribution of scores around the threshold. The non-
parametric method of calculating the bandwidth uses observa-
tions close to the threshold.27 Therefore, although our data-driven
bandwidth choice is claimed to be optimal, it ignores the observa-
tions outside of the bandwidth. This is why non-parametric meth-
ods tend to be less precise than parametric methods for a given
sample.24 In the present study, we accounted for this by looking at
the estimates of different RDD models given different bandwidths.
In conclusion, our results suggest that it could be worthwhile
for antimicrobial stewardship programmes to incorporate regular
social norm feedback into their activities, as a part of their strategy.
We found that on average feedback was effective, but it was not
effective for the top 10% of prescribing practices and future re-
search could investigate why. Individual-level feedback is likely to
be even more effective, but data by prescriber are not yet centrally
available in England. The effectiveness of social feedback may also
generalize to other domains, including antibiotic prescribing that
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evidence suggests that there may be high levels of inappropriate
prescribing or over-use of clinical tests.
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